Episode 42: Darnisha Harrison - Using Therapeutics to Tackle COVID-19

LSU Experimental

Treść dostarczona przez LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.

3y ago 41:51

MP3•Źródło odcinka

COVID-19 has upended our lives in how we interact and function. As of September 2021, the Centers for Disease Control estimate over 40 million people have been sick and approximately 652,000 people have died in the United States. We see that vaccines and mask-wearing are effective in controlling the spread, but people are still getting sick. We can’t fully eradicate COVID, but what if we could more effectively treat the symptoms of those infected and shorten the duration of their illness? LSU alumna, Darnisha Harrison, the Founder, President & CEO of Ennaid Therapeutics is working to answer that question. In this episode, Darnisha shares the inception of her company and the driving, divine mission to tackle diseases and identify treatments suitable for all of society. Catch more of Darnisha Harrison's story on a previous post on Science Next, "Will it take more than a vaccine to beat the Coronavirus?" Learn about Ennaid Therapeutics: https://ennaidthera.com/

5 odcinki

#LSU Experimental #LSU College of Science #LSU Communication across the Curriculum #Podcasting Education